| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3031547 | Trends in Cardiovascular Medicine | 2006 | 6 Pages |
Abstract
There is growing evidence of the potential role of hepatocyte growth factor (HGF) in various cardiovascular diseases. In addition to the beneficial effects of HGF in myocardial infarction, heart failure, and occlusive peripheral arterial disease, administration of HGF effectively suppresses acute and chronic cardiac allograft rejection and autoimmune myocarditis. The present review summarizes recent advances in the utility of HGF for heart diseases, especially immune-mediated heart diseases. Possible mechanisms of action in the suppression of T-cell-mediated immunity are also discussed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mitsuaki Isobe, Hideki Futamatsu, Jun-ichi Suzuki,